Compelling evidence gained from PLD2 overexpression (63), an isoform of PC-PLD gene, in low-invasive breast cancer cells resulted in the conversion of these cells into a highly aggressive phenotype with increased capacity of lung metastasis formation, which was inhibited by two different small-molecule inhibitors of PC-PLD activity (63). The gene discussed is PLD2; the disease is breast carcinoma.